Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) ROCE %: -6.53% (As of Mar. 2026)


SHSE:603168 Zhejiang Shapuaisi Pharmaceutical Co Ltd SHSE:603168
37 GF Score
Price ¥4.97
GF Value ¥8.60
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zhejiang Shapuaisi Pharmaceutical Co ROCE %?

Zhejiang Shapuaisi Pharmaceutical Co SHSE:603168 37 ROCE % is -6.53% as of Mar. 2026. GuruFocus rates SHSE:603168 with a GF Score™ of 37/100 and a GF Value™ of ¥8.60 (Significantly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhejiang Shapuaisi Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2026 was -6.53%.

Zhejiang Shapuaisi Pharmaceutical Co  (SHSE:603168) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhejiang Shapuaisi Pharmaceutical Co ROCE % Related Terms

Zhejiang Shapuaisi Pharmaceutical Co ROCE % Historical Data

* Premium members only.

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Shapuaisi Pharmaceutical Co ROCE % Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.66 3.54 2.01 -6.17 -14.46

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.51 3.37 1.26 -64.78 -6.53
SHSE:603168
37GF Score
Zhejiang Shapuaisi Pharmaceutical Co Ltd SHSE:603168
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Shapuaisi Pharmaceutical Co ROCE % Calculation

Zhejiang Shapuaisi Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-231.99/( ( (2106.253 - 377.473) + (1872.251 - 391.295) )/ 2 )
=-231.99/( (1728.78+1480.956)/ 2 )
=-231.99/1604.868
=-14.46 %

Zhejiang Shapuaisi Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-95.804/( ( (1872.251 - 391.295) + (1771.048 - 318.491) )/ 2 )
=-95.804/( ( 1480.956 + 1452.557 )/ 2 )
=-95.804/1466.7565
=-6.53 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -6.53% mean?
Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) has a ROCE % of -6.53% as of Mar. 2026.
Is Zhejiang Shapuaisi Pharmaceutical Co's ROCE % too high?
Zhejiang Shapuaisi Pharmaceutical Co's current ROCE % is -6.53%. Overall, Zhejiang Shapuaisi Pharmaceutical Co has a GF Score™ of 37/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Shapuaisi Pharmaceutical Co's ROCE % compare to ZTS and UTHR?
Zhejiang Shapuaisi Pharmaceutical Co's ROCE % of -6.53% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Shapuaisi Pharmaceutical Co's current ROCE % is -6.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Shapuaisi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥8.60, compared to a current price of ¥4.97 — trading 42.2% below its estimated fair value. The current ROCE % is -6.53%. Zhejiang Shapuaisi Pharmaceutical Co's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168), the current ROCE % is -6.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥4.97 is trading 42.2% below its estimated GF Value™ of ¥8.60. GuruFocus considers Zhejiang Shapuaisi Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:603168:

  • ROCE %: -6.53%
  • GF Value™: ¥8.60 vs. price of ¥4.97 (42.2% below fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Shapuaisi Pharmaceutical Co Business Description

Address No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
37GF Score

Get the complete analysis for SHSE:603168

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.97
Price
¥8.60
GF Value